Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Lactoferrin inhibits Porphyromonas gingivalis proteinases and has sustained biofilm inhibitory activity.

Dashper SG, Pan Y, Veith PD, Chen YY, Toh EC, Liu SW, Cross KJ, Reynolds EC.

Antimicrob Agents Chemother. 2012 Mar;56(3):1548-56. doi: 10.1128/AAC.05100-11. Epub 2012 Jan 3.

2.

Porphyromonas gingivalis gingipains: the molecular teeth of a microbial vampire.

O-Brien-Simpson NM, Veith PD, Dashper SG, Reynolds EC.

Curr Protein Pept Sci. 2003 Dec;4(6):409-26. Review.

PMID:
14683427
3.

Role of RgpA, RgpB, and Kgp proteinases in virulence of Porphyromonas gingivalis W50 in a murine lesion model.

O'Brien-Simpson NM, Paolini RA, Hoffmann B, Slakeski N, Dashper SG, Reynolds EC.

Infect Immun. 2001 Dec;69(12):7527-34.

4.

Hemoglobin hydrolysis and heme acquisition by Porphyromonas gingivalis.

Dashper SG, Cross KJ, Slakeski N, Lissel P, Aulakh P, Moore C, Reynolds EC.

Oral Microbiol Immunol. 2004 Feb;19(1):50-6.

PMID:
14678474
5.

Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia.

Wakabayashi H, Yamauchi K, Kobayashi T, Yaeshima T, Iwatsuki K, Yoshie H.

Antimicrob Agents Chemother. 2009 Aug;53(8):3308-16. doi: 10.1128/AAC.01688-08. Epub 2009 May 18.

6.
7.
8.

Propeptide-mediated inhibition of cognate gingipain proteinases.

Huq NL, Seers CA, Toh EC, Dashper SG, Slakeski N, Zhang L, Ward BR, Meuric V, Chen D, Cross KJ, Reynolds EC.

PLoS One. 2013 Jun 10;8(6):e65447. doi: 10.1371/journal.pone.0065447. Print 2013.

9.

The RgpA-Kgp proteinase-adhesin complexes of Porphyromonas gingivalis Inactivate the Th2 cytokines interleukin-4 and interleukin-5.

Tam V, O'Brien-Simpson NM, Chen YY, Sanderson CJ, Kinnear B, Reynolds EC.

Infect Immun. 2009 Apr;77(4):1451-8. doi: 10.1128/IAI.01377-08. Epub 2009 Jan 21.

10.

The role of gingipains in the pathogenesis of periodontal disease.

Imamura T.

J Periodontol. 2003 Jan;74(1):111-8. Review.

PMID:
12593605
12.

Generation of lys-gingipain protease activity in Porphyromonas gingivalis W50 is independent of Arg-gingipain protease activities.

Aduse-Opoku J, Davies NN, Gallagher A, Hashim A, Evans HE, Rangarajan M, Slaney JM, Curtis MA.

Microbiology. 2000 Aug;146 ( Pt 8):1933-40.

PMID:
10931897
13.

Hemagglutinin/Adhesin domains of Porphyromonas gingivalis play key roles in coaggregation with Treponema denticola.

Ito R, Ishihara K, Shoji M, Nakayama K, Okuda K.

FEMS Immunol Med Microbiol. 2010 Dec;60(3):251-60. doi: 10.1111/j.1574-695X.2010.00737.x. Epub 2010 Oct 6.

14.

Characterization of proteinase-adhesin complexes of Porphyromonas gingivalis.

Pathirana RD, O'Brien-Simpson NM, Veith PD, Riley PF, Reynolds EC.

Microbiology. 2006 Aug;152(Pt 8):2381-94.

PMID:
16849802
15.

An immune response directed to proteinase and adhesin functional epitopes protects against Porphyromonas gingivalis-induced periodontal bone loss.

O'Brien-Simpson NM, Pathirana RD, Paolini RA, Chen YY, Veith PD, Tam V, Ally N, Pike RN, Reynolds EC.

J Immunol. 2005 Sep 15;175(6):3980-9.

16.

Cleavage of IgG1 in gingival crevicular fluid is associated with the presence of Porphyromonas gingivalis.

Guentsch A, Hirsch C, Pfister W, Vincents B, Abrahamson M, Sroka A, Potempa J, Eick S.

J Periodontal Res. 2013 Aug;48(4):458-65. doi: 10.1111/jre.12027. Epub 2012 Nov 1.

17.
18.

Porphyromonas gingivalis cysteine proteinase inhibition by kappa-casein peptides.

Toh EC, Dashper SG, Huq NL, Attard TJ, O'Brien-Simpson NM, Chen YY, Cross KJ, Stanton DP, Paolini RA, Reynolds EC.

Antimicrob Agents Chemother. 2011 Mar;55(3):1155-61. doi: 10.1128/AAC.00466-10. Epub 2010 Dec 20.

19.
20.

Attenuation of the virulence of Porphyromonas gingivalis by using a specific synthetic Kgp protease inhibitor.

Curtis MA, Aduse Opoku J, Rangarajan M, Gallagher A, Sterne JA, Reid CR, Evans HE, Samuelsson B.

Infect Immun. 2002 Dec;70(12):6968-75.

Supplemental Content

Support Center